An announcement from Emergent Biosolutions (EBS) is now available.
Emergent BioSolutions Inc. has amended its senior secured credit agreement, enabling a forbearance period during which lenders will not exercise rights related to specified defaults, and allowing the company to secure additional credit under set conditions. The agreement also adjusts interest rates, prepayment terms, and requires further collateral, including a new guarantor. This adjustment aims to provide the company with financial flexibility, despite a payment of a $1.2 million forbearance fee.
For a thorough assessment of EBS stock, go to TipRanks’ Stock Analysis page.
